Therapeutic potential of phytochemicals for cystic fibrosis

被引:4
|
作者
Baharara, Hamed [1 ]
Kesharwani, Prashant [2 ,3 ]
Johnston, Thomas P. [4 ]
Sahebkar, AmirHossein [5 ,6 ,7 ]
机构
[1] Mashhad Univ Med Sci, Sch Pharm, Dept Clin Pharm, Mashhad, Iran
[2] Jamia Hamdard, Sch Pharmaceut Educ & Res, Dept Pharmaceut, New Delhi, India
[3] Saveetha Inst Med & Tech Sci, Saveetha Dent Coll, Ctr Transdisciplinary Res, Dept Pharmacol, Chennai, India
[4] Univ Missouri Kansas City, Sch Pharm, Div Pharmacol & Pharmaceut Sci, Kansas City, MO USA
[5] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Iran
[6] Mashhad Univ Med Sci, Appl Biomed Res Ctr, Mashhad, Iran
[7] Mashhad Univ Med Sci, Sch Pharm, Dept Biotechnol, Mashhad, Iran
关键词
baicalein; capsaicin; coumarin; curcumin; cystic fibrosis; genistein; phytomedicine; quercetin; resveratrol; TRANSMEMBRANE CONDUCTANCE REGULATOR; NATURAL COMPOUND CURCUMIN; CHLORIDE-CHANNEL; WILD-TYPE; SURFACE EXPRESSION; NUCLEOTIDE-BINDING; DELTA-F508; CFTR; CELL-CULTURE; IN-VITRO; GENISTEIN;
D O I
10.1002/biof.1960
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The aim of this review was to review and discuss various phytochemicals that exhibit beneficial effects on mutated membrane channels, and hence, improve transmembrane conductance. These therapeutic phytochemicals may have the potential to decrease mortality and morbidity of CF patients. Four databases were searched using keywords. Relevant studies were identified, and related articles were separated. Google Scholar, as well as gray literature (i.e., information that is not produced by commercial publishers), were also checked for related articles to locate/identify additional studies. The relevant databases were searched a second time to ensure that recent studies were included. In conclusion, while curcumin, genistein, and resveratrol have demonstrated effectiveness in this regard, it should be emphasized that coumarins, quercetin, and other herbal medicines also have beneficial effects on transporter function, transmembrane conductivity, and overall channel activity. Additional in vitro and in vivo studies should be conducted on mutant CFTR to unequivocally define the mechanism by which phytochemicals alter transmembrane channel function/activity, since the results of the studies evaluated in this review have a high degree of heterogenicity and discrepancy. Finally, continued research be undertaken to clearly define the mechanism(s) of action and the therapeutic effects that therapeutic phytochemicals have on the symptoms observed in CF patients in an effort to reduce mortality and morbidity.
引用
收藏
页码:984 / 1009
页数:26
相关论文
共 50 条
  • [41] Potential of Intestinal Current Measurement for Personalized Treatment of Patients with Cystic Fibrosis
    Graeber, Simon Y.
    Vitzthum, Constanze
    Mall, Marcus A.
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (05):
  • [42] Saliva as a potential tool for cystic fibrosis diagnosis
    Goncalves, Aline Cristina
    de Lima Marson, Fernando Augusto
    de Holanda Mendonca, Regina Maria
    Ribeiro, Jose Dirceu
    Ribeiro, Antonio Fernando
    Paschoal, Ilma Aparecida
    Levy, Carlos Emilio
    DIAGNOSTIC PATHOLOGY, 2013, 8
  • [43] PDE5 inhibitors as potential tools in the treatment of cystic fibrosis
    Noel, Sabrina
    Dhooghe, Barbara
    Leal, Teresinha
    FRONTIERS IN PHARMACOLOGY, 2012, 3
  • [44] Cystic fibrosis: current therapeutic targets and future approaches
    Rafeeq, Misbahuddin M.
    Murad, Hussam Aly Sayed
    JOURNAL OF TRANSLATIONAL MEDICINE, 2017, 15
  • [45] Saliva as a potential tool for cystic fibrosis diagnosis
    Aline Cristina Gonçalves
    Fernando Augusto de Lima Marson
    Regina Maria de Holanda Mendonça
    José Dirceu Ribeiro
    Antonio Fernando Ribeiro
    Ilma Aparecida Paschoal
    Carlos Emílio Levy
    Diagnostic Pathology, 8
  • [46] Pulmonary fibrosis: Therapeutic and mechanistic insights into the role of phytochemicals
    Hosseini, Seyede Atefe
    Zahedipour, Fatemeh
    Sathyapalan, Thozhukat
    Jamialahmadi, Tannaz
    Sahebkar, Amirhossein
    BIOFACTORS, 2021, 47 (03) : 250 - 269
  • [47] Anti-inflammatory action of lipid nanocarrier-delivered myriocin: therapeutic potential in cystic fibrosis
    Caretti, Anna
    Bragonzi, Alessandra
    Facchini, Marcella
    De Fino, Ida
    Riva, Camilla
    Gasco, Paolo
    Musicanti, Claudia
    Casas, Josefina
    Fabrias, Gemma
    Ghidoni, Riccardo
    Signorelli, Paola
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2014, 1840 (01): : 586 - 594
  • [48] Disparities and therapeutic advances in cystic fibrosis
    Palla, John B.
    PEDIATRIC PULMONOLOGY, 2024, 59 (12) : 3812 - 3818
  • [49] Therapeutic guidelines for the treatment of cystic fibrosis
    Becheva, Maria
    Atanasov, Petar
    PHARMACIA, 2021, 68 (01) : 151 - 154
  • [50] Therapeutic advances in cystic fibrosis in 2014
    Durupt, S.
    Mazur, S.
    Reix, P.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2016, 72 (01) : 77 - 86